4/A

FORM 4/A SUBMISSION

Company: Vanda Pharmaceuticals Inc.
Filed: February 13, 2012
Period of Report: August 22, 2011
Accession Number: 0001209191-12-009621

View Document ↗ View on SEC.gov ↗